

Cover Story
Guest Editorial
As the world faced the threat of a novel respiratory pathogen, SARS-CoV-2, in the first months of 2020, there was a great deal of uncertainty about its effect on people, especially those living with a diagnosis of cancer.
In Brief


Clinical Roundup


Drugs & Targets


Trending Stories
- Elisa Rodriguez named first chief diversity and equity officer for faculty at Roswell Park
- Nancy Goodman: “Sen. Sanders says he cares about kids with cancer. I’m just asking him to show us.”
- Gregory Curt, Clinician and Drug Developer, Dies at 64
- Mikaela Naylon Give Kids a Chance Act nixed by Senate
- Otis Brawley looks back on a year of great science and greater challenges
- GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation














